3050905-85-3
Chemical Structure
Nε-(Carboxyethyl)lysine-d4
- CAS No.: 3050905-85-3
- Formula:C9H14D4N2O4
- Molecular Weight:222.27
InChIKey: XCYPSOHOIAZISD-GBWCEIHOSA-N
SMILES: CC(C(O)=O)NCC([2H])([2H])C([2H])([2H])C[C@H](N)C(O)=O
Biological Activity: Nε-(Carboxyethyl)lysine-d4 is deuterium-labeled Nε-(Carboxyethyl)lysine[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Nε-(Carboxyethyl)lysine-d4 | Nε-(Carboxyethyl)lysine-d4 is deuterium-labeled Nε-(Carboxyethyl)lysine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nε-(Carboxyethyl)lysine | 99.97% | Nε-(Carboxyethyl) lysine is an advanced glycation end product (AGE). Nε-(Carboxyethyl) lysine induces cross-linking between proteins, thereby affecting protein structure and function and causing protein denaturation. Nε-(Carboxyethyl) lysine binds to the RAGE receptor, affects cell signal transduction, and regulates processes such as inflammatory responses, cell proliferation, and apoptosis. Nε-(Carboxyethyl) lysine affects glutamate transporters, reduces glutamate uptake and S100β protein secretion, influences neurotransmission in the nervous system, and exhibits diabetes-related neurotoxicity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||